Cannabis Law Report

OCTOBER 6, 2021

NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Cannabis Law Report

JUNE 4, 2021

Dr. Titus holds a Fellowship with the American Academy of Pain Management and clinical association with the American Association of Integrative Medicine. Colorado’s MED has just banned the sale of Delta 8 in rec retail. First up we posed a number of questions on Delta 8 to. Dr Stuart Titus the CEO at Medical Marijuana Inc.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

MARCH 29, 2020

This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . Authored By: Arundati Dandapani. Moreover, quality remains the top criterion in selecting a cannabis product for purchase.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state.

Law 40

Law Seed-To-Sale Hemp Recreational 40